NRG GU 006 – A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or Without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer.
1. WHAT TYPE OF CANCER? WHAT STAGE?
Prostate cancer that has recurred after surgery.
2. WHO IS ELIGIBLE?
Men who will be treated with salvage radiation therapy.
3. HOW WILL I BE TREATED?
This trial looks at adding in apalutamide, an anti-androgen that is approved in the treatment of prostate cancer.
For Physicians: More information about this specific trial at clinicaltrials.gov